Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
2.004
-0.006 (-0.29%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Nephros Market Cap
Nephros has a market cap or net worth of $21.24 million as of April 29, 2025. Its market cap has increased by 0.68% in one year.
Market Cap
21.24M
Enterprise Value
18.90M
1-Year Change
0.68%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $21.24M, a decrease of -60.73%. That is a compound annual growth rate of -15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 21.20M | 36.77% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |